Literature DB >> 22415763

Rett networked database: an integrated clinical and genetic network of Rett syndrome databases.

Elisa Grillo1, Laurent Villard, Angus Clarke, Bruria Ben Zeev, Mercedes Pineda, Nadia Bahi-Buisson, Anna Hryniewiecka-Jaworska, Thierry Bienvenu, Judith Armstrong, Ana Roche-Martinez, Francesca Mari, Edvige Veneselli, Silvia Russo, Aglaia Vignoli, Giorgio Pini, Milena Djuric, Anne-Marie Bisgaard, Vlatka Mejaški Bošnjak, Noémi Polgár, Francesca Cogliati, Kirstine Ravn, Maria Pintaudi, Béla Melegh, Dana Craiu, Aleksandra Djukic, Alessandra Renieri.   

Abstract

Rett syndrome (RTT) is a neurodevelopmental disorder with one principal phenotype and several distinct, atypical variants (Zappella, early seizure onset and congenital variants). Mutations in MECP2 are found in most cases of classic RTT but at least two additional genes, CDKL5 and FOXG1, can underlie some (usually variant) cases. There is only limited correlation between genotype and phenotype. The Rett Networked Database (http://www.rettdatabasenetwork.org/) has been established to share clinical and genetic information. Through an "adaptor" process of data harmonization, a set of 293 clinical items and 16 genetic items was generated; 62 clinical and 7 genetic items constitute the core dataset; 23 clinical items contain longitudinal information. The database contains information on 1838 patients from 11 countries (December 2011), with or without mutations in known genes. These numbers can expand indefinitely. Data are entered by a clinician in each center who supervises accuracy. This network was constructed to make available pooled international data for the study of RTT natural history and genotype-phenotype correlation and to indicate the proportion of patients with specific clinical features and mutations. We expect that the network will serve for the recruitment of patients into clinical trials and for developing quality measures to drive up standards of medical management.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415763     DOI: 10.1002/humu.22072

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

Review 1.  Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities.

Authors:  Kazuki Yoshida; Helga Radner; Arthur Kavanaugh; Yoon-Kyoung Sung; Sang-Cheol Bae; Mitsumasa Kishimoto; Kazuo Matsui; Masato Okada; Shigeto Tohma; Michael E Weinblatt; Daniel H Solomon
Journal:  Clin Exp Rheumatol       Date:  2013-10-03       Impact factor: 4.473

Review 2.  Investigation of Rett syndrome using pluripotent stem cells.

Authors:  Rana Dajani; Sung-Eun Koo; Gareth J Sullivan; In-Hyun Park
Journal:  J Cell Biochem       Date:  2013-11       Impact factor: 4.429

3.  iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome.

Authors:  Elisa Landucci; Margherita Brindisi; Laura Bianciardi; Lorenza M Catania; Sergio Daga; Susanna Croci; Elisa Frullanti; Chiara Fallerini; Stefania Butini; Simone Brogi; Simone Furini; Riccardo Melani; Angelo Molinaro; Flaminia Clelia Lorenzetti; Valentina Imperatore; Sonia Amabile; Jessica Mariani; Francesca Mari; Francesca Ariani; Tommaso Pizzorusso; Anna Maria Pinto; Flora M Vaccarino; Alessandra Renieri; Giuseppe Campiani; Ilaria Meloni
Journal:  Exp Cell Res       Date:  2018-05-04       Impact factor: 4.145

4.  Development of the Tailored Rett Intervention and Assessment Longitudinal (TRIAL) database and the Rett Evaluation of Symptoms and Treatments (REST) Questionnaire.

Authors:  Paramala Santosh; Kate Lievesley; Federico Fiori; Jatinder Singh
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

5.  MECP2 variation in Rett syndrome-An overview of current coverage of genetic and phenotype data within existing databases.

Authors:  Gillian S Townend; Friederike Ehrhart; Henk J van Kranen; Mark Wilkinson; Annika Jacobsen; Marco Roos; Egon L Willighagen; David van Enckevort; Chris T Evelo; Leopold M G Curfs
Journal:  Hum Mutat       Date:  2018-05-21       Impact factor: 4.878

6.  Suppressor mutations in Mecp2-null mice implicate the DNA damage response in Rett syndrome pathology.

Authors:  Adebola Enikanolaiye; Julie Ruston; Rong Zeng; Christine Taylor; Marijke Schrock; Christie M Buchovecky; Jay Shendure; Elif Acar; Monica J Justice
Journal:  Genome Res       Date:  2020-04-21       Impact factor: 9.043

Review 7.  Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome.

Authors:  Helen Leonard; Wendy Gold; Rodney Samaco; Mustafa Sahin; Timothy Benke; Jenny Downs
Journal:  Orphanet J Rare Dis       Date:  2022-03-04       Impact factor: 4.123

8.  CDKL5 regulates flagellar length and localizes to the base of the flagella in Chlamydomonas.

Authors:  Lai-Wa Tam; Paul T Ranum; Paul A Lefebvre
Journal:  Mol Biol Cell       Date:  2013-01-02       Impact factor: 4.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.